Efficacy and safety results from OCTAVIA, a single-arm phase II study evaluating front-line bevacizumab, carboplatin and weekly paclitaxel for ovarian cancer

1. Gonzalez-Martin, A.
2. Gladieff, L.
3. Tholander, B.
4. Stroyakovsky, D.
5. Gore, M.
6. Scambia, G.
7. Kovalenko, N.
8. Oaknin, A.
9. Ronco, J.P.
10. Freudensprung, U.
11. Pignata, S.